SCHEMBL10270126

SCHEMBL10270126

CC(C)CCNC(=O)[C@H]1CC[C@@H](C(C)C)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.57
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
EPHX2 P34913 1/20 0.46
GAA P10253 2/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
RAB9A P51151 1/20 0.45
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 2/20 0.44
MAPT P10636 1/20 0.44
ROCK2 O75116 1/20 0.44
ROCK1 Q13464 1/20 0.44
LMNA P02545 2/20 0.43
HTT P42858 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PSMB5 P28074 1/20 0.40
MMP2 P08253 1/20 0.40
MMP8 P22894 1/20 0.40
NAAA Q02083 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22509724 1.00 HSD17B10 (0.57) HSD17B10MEN1KMT2AEPHX2GAA
SCHEMBL7750667 0.91 HSD17B10 (0.66) HSD17B10MEN1KMT2AEPHX2GAA
SCHEMBL25801598 0.90 HSD17B10 (0.48) HSD17B10MEN1KMT2AEPHX2GAA
SCHEMBL10270570 0.84 ROCK2 (0.45) HSD17B10MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL23119218 0.84 HSD17B10 (0.59) HSD17B10MEN1KMT2AEPHX2GAA
SCHEMBL12197922 0.84 HSD17B10 (0.59) HSD17B10MEN1KMT2AEPHX2GAA
SCHEMBL15199100 0.84 HSD17B10 (0.59) HSD17B10MEN1KMT2AEPHX2GAA
SCHEMBL6385930 0.84 HSD17B10 (0.62) HSD17B10MEN1KMT2AEPHX2GAA
SCHEMBL12384303 0.84 HSD17B10 (0.62) HSD17B10MEN1KMT2AEPHX2GAA
SCHEMBL10270129 0.82 ROCK2 (0.46) HSD17B10KMT2AEPHX2ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018668-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC. (US) 2012-02-09 WO disclosed